Signaling Protein Seen to Help Promote Myelin-making Cells
by Marisa Wexler MS | July 28, 2021 A signaling protein called fractalkine helps to regulate the development of oligodendrocytes, cells of the…
• Gray Matter in Hippocampus Can Help Distinguish Between Two MS Types
by Marisa Wexler MS | July 27, 2021 Subtle changes in structure in the hippocampus — a region of the…
Stuart Schlossman
Considerations for the Use of Fumarates in Relapsing MS
July 24, 2021 Fred D. Lublin, MD, Ravi Dukkipati, MD, Gavin Giovannoni, MD , Lauren Gluck, MD CLICK IMAGE TO…
Stuart Schlossman
Prevalence of MS and NMOSD in Indigenous Populations Dependent on Ancestry
Investigators evaluated the occurrence of multiple sclerosis and neuromyelitis optica spectrum disorder in Australian and New Zealand Indigenous populations, comparing…
Stuart Schlossman
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
By DocWire News Featured Reading -July 24, 2021 ABSTRACT Currently, there is still no cure for multiple sclerosis (MS), which…
Stuart Schlossman
Do you have #MS, but are unsure if you should have the COVID-19 vaccine?
Research study on MS & COVID-19 vaccine: Curious? Read more below READ THE CONSENT FORM About the Research Study…
Stuart Schlossman
MS Trial Evaluating ATA188 in Progressive MS
Evaluating ATA188 in Progressive MS: Jakob Dupont, MD, MA Part 2 of a phase 1, multicenter study evaluating the safety/tolerability,…
Stuart Schlossman
STEP for MS exercise study
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Stuart Schlossman
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French…
Click HERE to Subscribe for the MS Beacon eNewsletter Abstract Background: As healthcare management of highly active-relapsing-remitting multiple sclerosis (HA-RRMS) patients…
Stuart Schlossman
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
Abstract Background The use of mesenchymal stem cells (MSCs) is being extensively studied in clinical trials in the setting…
Stuart Schlossman
